Older age is associated with peripheral blood expansion of Näive B cells in HIV-infected subjects on antiretroviral therapy

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Van Epps, Puja ^a   Matining, Roy M ^b   Tassiopoulos, Katherine ^b   Anthony, Donald D ^a   Landay, Alan ^c   Kalayjian, Robert C ^d,e   Canaday, David H ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS A VACCINE; TETANUS TOXOID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BACTERIUM ANTIBODY; VIRUS ANTIBODY;

ADULT; AGE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS A; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; TETANUS; VACCINATION; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL TRIAL; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE COUNT; MIDDLE AGED; PATHOLOGY; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-HIV AGENTS; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; HEPATITIS A VACCINES; HIV; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; TETANUS TOXOID;

EID: 84928828230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107064     Document Type: Article

References (24)

1. Moir S, Malaspina A, Ho J, Wang W, Dipoto AC, et al. (2008) Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J Infect Dis 197: 572-579.
2. Moir S, Fauci AS (2008) Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 122: 12-19; quiz 20-11.
3. Moir S, Fauci AS (2009) B cells in HIV infection and disease. Nat Rev Immunol 9: 235-245.
4. Moir S, Buckner CM, Ho J, Wang W, Chen J, et al. (2010) B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood 116: 5571-5579.
5. Ho J, Moir S, Malaspina A, Howell ML, Wang W, et al. (2006) Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms. Proc Natl Acad Sci U S A 103: 19436-19441.
6. Weksler ME, Szabo P (2000) The effect of age on the B-cell repertoire. J Clin Immunol 20: 240-249.
7. Bhatia R, Ryscavage P, Taiwo B (2012) Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol 18: 247-255.
8. Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62: 141-155.
9. Pensieroso S, Galli L, Nozza S, Ruffin N, Castagna A, et al. (2013) B-cell subset alterations and correlated factors in HIV-1 infection. AIDS.
10. Kalayjian RC, Spritzler J, Matining RM, Fiscus SA, Gross BH, et al. (2013) Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. AIDS 27: 1563-1571 1510.1097/QAD.1560b1013e32835fabc32832.
11. Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, et al. (2003) Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis 187: 1924-1933.
12. Colonna-Romano G, Bulati M, Aquino A, Vitello S, Lio D, et al. (2008) B cell immunosenescence in the elderly and in centenarians. Rejuvenation Res 11: 433-439.
13. Listi F, Candore G, Modica MA, Russo M, Di Lorenzo G, et al. (2006) A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci 1089: 487-495.
14. Mauch P, Botnick LE, Hannon EC, Obbagy J, Hellman S (1982) Decline in bone marrow proliferative capacity as a function of age. Blood 60: 245-252.
15. Quiros-Roldan E, Serana F, Chiarini M, Zanotti C, Sottini A, et al. (2012) Effects of combined antiretroviral therapy on B-and T-cell release from production sites in long-term treated HIV-1+ patients. J Transl Med 10: 94.
16. Cabatingan MS, Schmidt MR, Sen R, Woodland RT (2002) Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol 169: 6795-6805.
17. Meyer-Bahlburg A, Andrews SF, Yu KO, Porcelli SA, Rawlings DJ (2008) Characterization of a late transitional B cell population highly sensitive to BAFFmediated homeostatic proliferation. J Exp Med 205: 155-168.
18. Demberg T, Brocca-Cofano E, Xiao P, Venzon D, Vargas-Inchaustegui D, et al. (2012) Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques. J Virol 86: 12591-12604.
19. Titanji K, Chiodi F, Bellocco R, Schepis D, Osorio L, et al. (2005) Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS 19: 1947-1955.
20. Ruffin N, Thang PH, Rethi B, Nilsson A, Chiodi F (2011) The impact of inflammation and immune activation on B cell differentiation during HIV-1 infection. Front Immunol 2: 90.
21. Jiang W (2012) Microbial Translocation and B Cell Dysfunction in Human Immunodeficiency Virus Disease. Am J Immunol 8: 44-51.
22. Barbi M, Biffi MR, Binda S, Clerici-Schoeller M, Ferraris G, et al. (1992) Immunization in children with HIV seropositivity at birth: antibody response to polio vaccine and tetanus toxoid. AIDS 6: 1465-1469.
23. Ryder RW, Oxtoby MJ, Mvula M, Batter V, Baende E, et al. (1993) Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 122: 697-702.
24. Alsina L, Noguera-Julian A, Fortuny C (2013) Impaired cellular immune response to tetanus toxoid but not to cytomegalovirus in effectively HAART-treated HIV-infected children. Vaccine 31: 2417-2419.